Twinlab Consolid Financials
This page shows Twinlab Consolid (TLCC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2023 annual data. Scores normalized against common benchmarks. How we calculate these scores
Twinlab Consolid has an operating margin of -10.2%, meaning the company retains $-10 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -10.4% the prior year.
Twinlab Consolid's revenue declined 20.9% year-over-year, from $17.2M to $13.6M. This contraction results in a growth score of 0/100.
Twinlab Consolid's current ratio of 0.04 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
Twinlab Consolid converts 21.3% of revenue into free cash flow ($2.9M). This strong cash generation earns a score of 100/100.
Twinlab Consolid passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Twinlab Consolid generates $-0.21 in operating cash flow ($2.9M OCF vs -$13.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Twinlab Consolid earns $-0.2 in operating income for every $1 of interest expense (-$1.4M vs $8.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Twinlab Consolid generated $13.6M in revenue in fiscal year 2023. This represents a decrease of 20.9% from the prior year.
Twinlab Consolid's EBITDA was -$1.4M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 16.1% from the prior year.
Twinlab Consolid generated $2.9M in free cash flow in fiscal year 2023, representing cash available after capex. This represents an increase of 165.7% from the prior year.
Twinlab Consolid reported -$13.7M in net income in fiscal year 2023. This represents a decrease of 66.8% from the prior year.
Twinlab Consolid earned $-0.05 per diluted share (EPS) in fiscal year 2023. This represents a decrease of 66.7% from the prior year.
Twinlab Consolid held $19K in cash against $0 in long-term debt as of fiscal year 2023.
Twinlab Consolid's gross margin was 36.8% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is down 10.8 percentage points from the prior year.
Twinlab Consolid's operating margin was -10.2% in fiscal year 2023, reflecting core business profitability. This is up 0.2 percentage points from the prior year.
Twinlab Consolid's net profit margin was -100.7% in fiscal year 2023, showing the share of revenue converted to profit. This is down 52.9 percentage points from the prior year.
Twinlab Consolid invested $0 in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.
TLCC Income Statement
| Metric | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M-25.5% | $3.1M+12.6% | $2.8M-11.9% | $3.1M+2.8% | $3.1M-18.2% | $3.7M | N/A | $4.6M |
| Cost of Revenue | $1.7M-11.2% | $1.9M-1.9% | $1.9M-9.5% | $2.1M+14.0% | $1.9M-17.3% | $2.3M | N/A | $2.7M |
| Gross Profit | $642K-47.6% | $1.2M+45.8% | $841K-17.0% | $1.0M-14.8% | $1.2M-19.6% | $1.5M | N/A | $1.9M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.3M+42.6% | $885K-4.5% | $927K-19.1% | $1.1M-7.7% | $1.2M-25.2% | $1.7M | N/A | $2.0M |
| Operating Income | -$746K-439.1% | $220K+220.2% | -$183K+73.2% | -$684K-124.3% | -$305K-54.0% | -$198K | N/A | -$917K |
| Interest Expense | $2.0M-0.4% | $2.0M-1.0% | $2.0M+8.0% | $1.8M-16.5% | $2.2M+4.2% | $2.1M | N/A | $2.1M |
| Income Tax | $0-100.0% | $6K | $0-100.0% | $12K+100.0% | $6K | $0 | N/A | $0 |
| Net Income | -$2.7M-70.4% | -$1.6M+25.0% | -$2.1M-35.3% | -$1.5M+61.2% | -$4.0M-42.0% | -$2.8M | N/A | -$2.9M |
| EPS (Diluted) | $-0.010.0% | $-0.010.0% | $-0.01 | $0.00+100.0% | $-0.02-100.0% | $-0.01 | N/A | $-0.01 |
TLCC Balance Sheet
| Metric | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.6M+4.9% | $7.3M-11.1% | $8.2M-8.8% | $9.0M-34.9% | $13.8M-18.2% | $16.9M-19.2% | $20.9M-16.0% | $24.9M |
| Current Assets | $5.0M+17.1% | $4.3M-15.3% | $5.0M-11.5% | $5.7M-39.4% | $9.4M-17.8% | $11.4M-24.6% | $15.1M-18.3% | $18.5M |
| Cash & Equivalents | $14K-94.7% | $265K+90.6% | $139K+631.6% | $19K-86.6% | $142K+40.6% | $101K-88.3% | $866K+202.8% | $286K |
| Inventory | $2.8M+15.2% | $2.4M-34.5% | $3.7M+7.5% | $3.4M-37.9% | $5.5M-26.5% | $7.5M+8.7% | $6.9M-35.0% | $10.6M |
| Accounts Receivable | $1.8M+52.7% | $1.2M+12.7% | $1.1M-44.0% | $1.9M-32.4% | $2.8M+18.2% | $2.4M+96.6% | $1.2M-83.6% | $7.4M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $153.0M+2.0% | $150.0M+0.4% | $149.3M+0.9% | $148.0M+1.4% | $145.9M+0.6% | $145.0M-0.8% | $146.2M-0.4% | $146.9M |
| Current Liabilities | $151.6M+2.2% | $148.3M+0.6% | $147.4M+1.1% | $145.8M+2.0% | $142.9M+1.2% | $141.3M-0.6% | $142.2M-0.2% | $142.5M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | -$145.4M-1.9% | -$142.7M-1.1% | -$141.1M-1.5% | -$139.0M-5.2% | -$132.1M-3.1% | -$128.1M-2.2% | -$125.3M-2.7% | -$122.0M |
| Retained Earnings | -$376.5M-0.7% | -$373.8M-0.4% | -$372.2M-0.6% | -$370.1M-1.9% | -$363.2M-1.1% | -$359.2M-0.8% | -$356.4M-0.9% | -$353.1M |
TLCC Cash Flow Statement
| Metric | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$327K-134.8% | $941K+4605.0% | $20K-98.8% | $1.7M+119.3% | $766K+215.2% | $243K-92.5% | $3.2M+221.8% | -$2.7M |
| Capital Expenditures | N/A | N/A | N/A | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | $1.7M+119.3% | $766K+215.2% | $243K-92.5% | $3.2M+221.8% | -$2.7M |
| Investing Cash Flow | N/A | N/A | N/A | $0 | N/A | N/A | $0 | N/A |
| Financing Cash Flow | $76K+109.3% | -$815K-915.0% | $100K+105.8% | -$1.7M-136.0% | -$725K+28.2% | -$1.0M+62.0% | -$2.7M-194.8% | $2.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
TLCC Financial Ratios
| Metric | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.7%-11.7pp | 39.3%+8.9pp | 30.4%-1.8pp | 32.2%-6.7pp | 38.9%-0.7pp | 39.6% | N/A | 41.0% |
| Operating Margin | -32.1%-39.2pp | 7.1%+13.7pp | -6.6%+15.1pp | -21.8%-11.8pp | -10.0%-4.7pp | -5.3% | N/A | -20.0% |
| Net Margin | -115.4%-65.0pp | -50.4%+25.3pp | -75.7%-26.4pp | -49.3%+81.2pp | -130.5%-55.4pp | -75.1% | N/A | -63.6% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -35.1%-13.5pp | -21.6%+4.0pp | -25.6%-8.3pp | -17.2%+11.7pp | -28.9%-12.3pp | -16.6% | N/A | -11.8% |
| Current Ratio | 0.030.0 | 0.030.0 | 0.030.0 | 0.04-0.0 | 0.07-0.0 | 0.08-0.0 | 0.11-0.0 | 0.13 |
| Debt-to-Equity | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.00 |
| FCF Margin | N/A | N/A | N/A | 53.4%+28.4pp | 25.1%+18.6pp | 6.5% | N/A | -57.8% |
Note: Shareholder equity is negative (-$139.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Twinlab Consolid's annual revenue?
Twinlab Consolid (TLCC) reported $13.6M in total revenue for fiscal year 2023. This represents a -20.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Twinlab Consolid's revenue growing?
Twinlab Consolid (TLCC) revenue declined by 20.9% year-over-year, from $17.2M to $13.6M in fiscal year 2023.
Is Twinlab Consolid profitable?
No, Twinlab Consolid (TLCC) reported a net income of -$13.7M in fiscal year 2023, with a net profit margin of -100.7%.
What is Twinlab Consolid's earnings per share (EPS)?
Twinlab Consolid (TLCC) reported diluted earnings per share of $-0.05 for fiscal year 2023. This represents a -66.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Twinlab Consolid's EBITDA?
Twinlab Consolid (TLCC) had EBITDA of -$1.4M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Twinlab Consolid have?
As of fiscal year 2023, Twinlab Consolid (TLCC) had $19K in cash and equivalents against $0 in long-term debt.
What is Twinlab Consolid's gross margin?
Twinlab Consolid (TLCC) had a gross margin of 36.8% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.
What is Twinlab Consolid's operating margin?
Twinlab Consolid (TLCC) had an operating margin of -10.2% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.
What is Twinlab Consolid's net profit margin?
Twinlab Consolid (TLCC) had a net profit margin of -100.7% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.
What is Twinlab Consolid's free cash flow?
Twinlab Consolid (TLCC) generated $2.9M in free cash flow during fiscal year 2023. This represents a 165.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Twinlab Consolid's operating cash flow?
Twinlab Consolid (TLCC) generated $2.9M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are Twinlab Consolid's total assets?
Twinlab Consolid (TLCC) had $9.0M in total assets as of fiscal year 2023, including both current and long-term assets.
What are Twinlab Consolid's capital expenditures?
Twinlab Consolid (TLCC) invested $0 in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.
What is Twinlab Consolid's current ratio?
Twinlab Consolid (TLCC) had a current ratio of 0.04 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Twinlab Consolid's debt-to-equity ratio?
Twinlab Consolid (TLCC) had a debt-to-equity ratio of 0.00 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Twinlab Consolid's return on assets (ROA)?
Twinlab Consolid (TLCC) had a return on assets of -152.5% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
Why is Twinlab Consolid's debt-to-equity ratio negative or unusual?
Twinlab Consolid (TLCC) has negative shareholder equity of -$139.0M as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Twinlab Consolid's Piotroski F-Score?
Twinlab Consolid (TLCC) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Twinlab Consolid's earnings high quality?
Twinlab Consolid (TLCC) has an earnings quality ratio of -0.21x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Twinlab Consolid cover its interest payments?
Twinlab Consolid (TLCC) has an interest coverage ratio of -0.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Twinlab Consolid?
Twinlab Consolid (TLCC) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.